Prescription drug
Where is Anhydrous Dextrose made?
12 companies sell it under their own name and 6 repackagers rebottle it. Their labels name 13 factories in the United States, Spain, Germany and Norway.
United States 10Spain 1Germany 1Norway 1
Companies and their factories
| Company on the label | Factory | Where | Last FDA inspection |
|---|---|---|---|
| Baxter Healthcare Corporation Dextrose2.5 g per 50 mL, 5 g per 100 mL, 50 g per 1000 mL, 70 g per 100 mL, 100 g per 1000 mL · NDC 0338-0023, 0338-9664, 0338-0204 +23 | Baxter Healthcare CorporationMakes it, tests it, packages it, labels it and sterilizes it | Marion, NC, United States | Serious problems, FDA actionFeb 2024 |
| Baxter Healthcare CorporationMakes it, tests it, packages it, labels it and sterilizes it | Jayuya, PR, United States | Problems found, fixed voluntarilyJul 2024 | |
| Baxter Healthcare CorporationMakes it, tests it, packages it, labels it and sterilizes it | Aibonito, PR, United States | Problems found, fixed voluntarilySep 2026 | |
| Bieffe Medital SAMakes it, tests it, packages it, labels it and sterilizes it | Sabinanigo (Senegue), Spain | Problems found, fixed voluntarilyApr 2025 | |
| Becton Dickinson and Company50 mg per 1 mL, 100 mg per 1 mL, 2500 mg per 50 mL · NDC 17271-721, 17271-772, 17271-720 | Fresenius Kabi Deutschland GmbHMakes it, makes the active ingredient and tests it | Friedberg, Germany | Problems found, fixed voluntarilyDec 2023 |
| Fresenius Kabi USA, LLCMakes it and tests it | Wilson, NC, United States | Problems found, fixed voluntarilyFeb 2026 | |
| HP Halden Pharma ASMakes it, tests it and packages it | Halden, Norway | Problems found, fixed voluntarilyMay 2023 | |
| Fresenius Kabi USA, LLC50 mg per 1 mL, 2500 mg per 50 mL, 5000 mg per 100 mL, 12500 mg per 250 mL, 25000 mg per 500 mL · NDC 65219-238, 65219-234, 65219-240 +6 | Fresenius Kabi Deutschland GmbHMakes it, makes the active ingredient and tests it | Friedberg, Germany | Problems found, fixed voluntarilyDec 2023 |
| Fresenius Kabi USA, LLCMakes it and tests it | Wilson, NC, United States | Problems found, fixed voluntarilyFeb 2026 | |
| HP Halden Pharma ASMakes it, tests it and packages it | Halden, Norway | Problems found, fixed voluntarilyMay 2023 | |
| Fresenius Kabi, LLC50 mg per 1 mL, 100 mg per 1 mL · NDC 63323-824, 63323-624 | Fresenius Kabi Deutschland GmbHMakes it, makes the active ingredient and tests it | Friedberg, Germany | Problems found, fixed voluntarilyDec 2023 |
| Fresenius Kabi USA, LLCMakes it and tests it | Wilson, NC, United States | Problems found, fixed voluntarilyFeb 2026 | |
| HP Halden Pharma ASMakes it, tests it and packages it | Halden, Norway | Problems found, fixed voluntarilyMay 2023 | |
| Hospira, Inc. Dextrose25 g per 50 mL, 50 mg per 1 mL, 250 mg per 1 mL · NDC 0409-7517, 0409-6648, 0409-1775 +1 | Hospira, Inc.Makes it, tests it, packages it and labels it | Rocky Mount, NC, United States | No problems foundFeb 2025 |
| Roquette America, Inc.Makes the active ingredient | Keokuk, IA, United States | Problems found, fixed voluntarilyJan 2026 | |
| B. Braun Medical Inc. Dextrose5 g per 100 mL, 10 g per 100 mL, 50 mg per 1 mL, 70 g per 100 mL · NDC 0264-7520, 0264-7510, 0264-1510 +1 | B. Braun US Pharmaceutical Manufacturing LLCMakes it, packages it and labels it | Irvine, CA, United States | Serious problems, FDA actionNov 2025 |
| GVS TM Inc Leukotrap WB system - CP2D, Blood Collection System, Leukotrap WB System - CP2D, Leukotrap RC System, Leukotrap RC PL System, Cp2d3.21 g per 63 mL, 3.57 g per 70 mL, 4.64 g per 100 mL · NDC 87069-726, 87069-121, 87069-126 +3 | GVS TM, IncMakes it | Covina, CA, United States | Problems found, fixed voluntarilySep 2019 |
| Haemonetics Manufacturing Inc. Leukotrap WB System - CP2D, Leukotrap - CP2D Solution3.57 g per 70 mL · NDC 53157-126, 53157-123, 53157-726 | Haemonetics Manufacturing IncMakes it and labels it | Location not on file | Not inspected on record |
| ICU Medical Inc. Dextrose5 g per 100 mL, 10 g per 100 mL, 20 g per 100 mL, 30 g per 100 mL, 40 g per 100 mL, 50 g per 100 mL · NDC 0990-7938, 0990-7930, 0990-7935 +7 | Otsuka ICU Medical LLCMakes it, tests it, packages it and labels it | Austin, TX, United States | Problems found, fixed voluntarilyMar 2017 |
| International Medication Systems, Ltd.25 g per 50 mL · NDC 76329-3302 | International Medication Systems, Ltd.Makes it and tests it | South El Monte, CA, United States | Serious problems, FDA actionDec 2025 |
| Turk Ilac Ve Serum Sanayi Anonim Sirketi5 g per 100 mL · NDC 85160-300 | Turk Ilac Ve Serum Sanayi Anonim SirketiMakes it | Location not on file | Not inspected on record |
| Huaren Pharmaceutical Co., Ltd.5 g per 100 mL, 10 g per 100 mL · NDC 85268-804, 85268-803 | The label doesn't name the factory. Plants this company names for other drugs | ||
Repackaged by
These companies buy Anhydrous Dextrose in bulk and rebottle it, often for mail-order, clinic or hospital pharmacies. If your bottle shows one of these names, open its NDC to see who made the pills inside.
- A-S Medication Solutions:
50090-2942 - HF Acquisition Co. LLC. DBA HealthFirst:
51662-1680,51662-1215,51662-1216,51662-1584+7 - Henry Schein, Inc.:
0404-9847,0404-9845,0404-9844 - Medical Purchasing Solutions, LLC.:
71872-7282,71872-7003,71872-7102,71872-7057+1 - ProPharma Distribution:
84549-517,84549-648,84549-460 - Remedyrepack Inc.:
70518-4159,70518-4219,70518-4452
Recalls
- Apr 2, 2026 · Class II · B Braun Medical Inc
Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed. - Mar 11, 2026 · Class II · Fresenius Kabi USA, LLC · 3 recall notices
Lack of Assurance of Sterility - Nov 30, 2021 · Class II · Pfizer Inc.
Lack of sterility assurance: bag has the potential to leak. - Nov 27, 2019 · Class II · Pfizer Inc.
Labeling: Incorrect or Missing Lot and/or expiration date. - Jul 6, 2017 · Class II · Baxter Healthcare Corporation
Lack of Assurance of Sterility: Bags have the potential to leak. - Apr 21, 2017 · Class I · Hospira Inc.
Presence of Particulate Matter: human hair found within an internal sample syringe. - Dec 15, 2015 · Class I · Baxter Healthcare Corp.
Presence of Particulate Matter: Confirmed customer compliants of finding an insect floating in the primary container of each product. - Mar 24, 2015 · Class I · Baxter Healthcare Corp. · 2 recall notices
Presence of Particulate Matter: Products recalled due to presence of particulate matter (metal) - Mar 18, 2015 · Class II · Baxter Healthcare Corp.
Lack of Assurance of Sterility. Complaints were receive of missing closures and/or leaks which may compromise product sterility. - Mar 5, 2015 · Class II · Hospira Inc.
Lack of Assurance of Sterility: there is a potential for solution to leak at the administrative port of the primary container. - Nov 21, 2013 · Class I · Baxter Healthcare Corp.
Presence of Paticulate Matter; Baxter is issuing a voluntary recall for these IV solutions due to particulate matter found in the solution identified as polyester and cotton fibers, adhesive-like mixture, polyacetal particles, thermally degraded PVC, black po… - May 21, 2013 · Class II · Baxter Healthcare Corp.
Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly a…
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.